Asensus Surgical Inc (ASXC) USD0.001
Asensus Surgical, Inc., formerly TransEnterix, Inc., is a medical device company. The Company is engaged in digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through digital laparoscopy. The Senhance system is a machine vision system for use in robotic surgery, which is powered by intelligent surgical unit that enables augmented intelligence in surgery. Its System is designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, advanced instrumentation, including three-millimeter micro laparoscopic instruments, eye-sensing camera control and reusable standard instruments to patients around the world. The Senhance System is used in Europe for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.